EP1861411A2 - Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique - Google Patents
Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutiqueInfo
- Publication number
- EP1861411A2 EP1861411A2 EP06726275A EP06726275A EP1861411A2 EP 1861411 A2 EP1861411 A2 EP 1861411A2 EP 06726275 A EP06726275 A EP 06726275A EP 06726275 A EP06726275 A EP 06726275A EP 1861411 A2 EP1861411 A2 EP 1861411A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- group
- pyridinyl
- thio
- xylopyranoside
- acetyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 137
- VKIZGCILTVKEFV-VPENINKCSA-N (2r,3r,4s)-2,3,4-trihydroxy-5-sulfanylpentanal Chemical compound SC[C@@H](O)[C@H](O)[C@@H](O)C=O VKIZGCILTVKEFV-VPENINKCSA-N 0.000 title abstract description 4
- 230000001225 therapeutic effect Effects 0.000 title description 3
- 238000002360 preparation method Methods 0.000 claims abstract description 72
- 239000003814 drug Substances 0.000 claims abstract description 8
- 230000002265 prevention Effects 0.000 claims abstract description 7
- 208000007536 Thrombosis Diseases 0.000 claims abstract description 5
- 206010019280 Heart failures Diseases 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 160
- -1 5-thio-β-D-xylopyranosyl group Chemical group 0.000 claims description 155
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 111
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 40
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 22
- 125000005843 halogen group Chemical group 0.000 claims description 17
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 11
- 150000002367 halogens Chemical class 0.000 claims description 11
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 11
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 8
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 7
- 239000007858 starting material Substances 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 6
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 5
- 239000000010 aprotic solvent Substances 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 239000002207 metabolite Substances 0.000 claims description 4
- QWVJFKXOINHVGD-IOVATXLUSA-N (3r,4s,5s)-thiane-2,3,4,5-tetrol Chemical class O[C@@H]1CSC(O)[C@H](O)[C@H]1O QWVJFKXOINHVGD-IOVATXLUSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims description 3
- 206010047249 Venous thrombosis Diseases 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003751 zinc Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000011968 lewis acid catalyst Substances 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 490
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 138
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 103
- 239000007787 solid Substances 0.000 description 102
- 239000000047 product Substances 0.000 description 91
- 239000000843 powder Substances 0.000 description 65
- 239000000203 mixture Substances 0.000 description 56
- 239000000243 solution Substances 0.000 description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 46
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 42
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 42
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 29
- 238000004587 chromatography analysis Methods 0.000 description 28
- 239000012074 organic phase Substances 0.000 description 28
- 239000013078 crystal Substances 0.000 description 24
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 24
- ZBUXQMYHQVQMEJ-QKPAOTATSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(5-bromopyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(Br)=C1 ZBUXQMYHQVQMEJ-QKPAOTATSA-N 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 21
- 239000000741 silica gel Substances 0.000 description 21
- 229910002027 silica gel Inorganic materials 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 20
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 18
- 235000019341 magnesium sulphate Nutrition 0.000 description 18
- 238000001704 evaporation Methods 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 230000008020 evaporation Effects 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- 239000012429 reaction media Substances 0.000 description 12
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 11
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000003054 catalyst Substances 0.000 description 10
- 239000003480 eluent Substances 0.000 description 10
- 239000000377 silicon dioxide Substances 0.000 description 10
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 9
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- CWGATHMNNMIICW-SLBVQIDZSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(6-bromopyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=C(Br)N=C1 CWGATHMNNMIICW-SLBVQIDZSA-N 0.000 description 8
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 8
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical class S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 7
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 239000012300 argon atmosphere Substances 0.000 description 6
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical class OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 5
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- HBBDZZGPHYPNMV-QKPAOTATSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(4-bromopyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC=C1Br HBBDZZGPHYPNMV-QKPAOTATSA-N 0.000 description 4
- DYMCBUANBWLDKP-QKPAOTATSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(4-iodopyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC=C1I DYMCBUANBWLDKP-QKPAOTATSA-N 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 239000012453 solvate Substances 0.000 description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- CEBAHYWORUOILU-UHFFFAOYSA-N (4-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=C(C#N)C=C1 CEBAHYWORUOILU-UHFFFAOYSA-N 0.000 description 3
- SJGGDZCTGBKBCK-UHFFFAOYSA-N 3-acetylphenylboronic acid Chemical compound CC(=O)C1=CC=CC(B(O)O)=C1 SJGGDZCTGBKBCK-UHFFFAOYSA-N 0.000 description 3
- NUEPJIDHJSTAJI-UHFFFAOYSA-N 4-(3-methoxypyridin-2-yl)benzonitrile Chemical compound COC1=CC=CN=C1C1=CC=C(C#N)C=C1 NUEPJIDHJSTAJI-UHFFFAOYSA-N 0.000 description 3
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- UDXTWHNZGVNUMV-HLPPOEQASA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(2-bromopyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=CN=C1Br UDXTWHNZGVNUMV-HLPPOEQASA-N 0.000 description 3
- MWYPHOWMKHNMBH-YTWAJWBKSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-bromothian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1CS[C@H](Br)[C@H](OC(C)=O)[C@H]1OC(C)=O MWYPHOWMKHNMBH-YTWAJWBKSA-N 0.000 description 3
- HUOFUOCSQCYFPW-UHFFFAOYSA-N [4-(trifluoromethoxy)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(OC(F)(F)F)C=C1 HUOFUOCSQCYFPW-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 238000003381 deacetylation reaction Methods 0.000 description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 3
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 2
- SWIYDICJOPIQHQ-BZZMCLGOSA-N (2r,3r,4s,5s)-2-[5-(2,4-dimethoxyphenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound COC1=CC(OC)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](O)[C@H](O)CS2)O)=C1 SWIYDICJOPIQHQ-BZZMCLGOSA-N 0.000 description 2
- XIFNAYGLKGAGNR-YYIAUSFCSA-N (2r,3r,4s,5s)-2-[5-(2-fluoro-5-methylphenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound CC1=CC=C(F)C(C=2C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)CS3)O)C=NC=2)=C1 XIFNAYGLKGAGNR-YYIAUSFCSA-N 0.000 description 2
- SAROVSKIPKCYSW-QKPAOTATSA-N (2r,3r,4s,5s)-2-[5-(2-fluorophenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C=2C(=CC=CC=2)F)=C1 SAROVSKIPKCYSW-QKPAOTATSA-N 0.000 description 2
- CUEHMMUFRVMVLY-XLNGHYISSA-N (2r,3r,4s,5s)-2-[5-(2-methoxyphenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound COC1=CC=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](O)[C@H](O)CS2)O)=C1 CUEHMMUFRVMVLY-XLNGHYISSA-N 0.000 description 2
- PEAIURKQMLSGQB-QKPAOTATSA-N (2r,3r,4s,5s)-2-[5-(3,4-difluorophenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C=2C=C(F)C(F)=CC=2)=C1 PEAIURKQMLSGQB-QKPAOTATSA-N 0.000 description 2
- CWLJXPHMQYXQDF-QKPAOTATSA-N (2r,3r,4s,5s)-2-[5-(3-chloro-4-fluorophenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C=2C=C(Cl)C(F)=CC=2)=C1 CWLJXPHMQYXQDF-QKPAOTATSA-N 0.000 description 2
- JHVSOYDRSVUHPP-QKPAOTATSA-N (2r,3r,4s,5s)-2-[5-(3-fluorophenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C=2C=C(F)C=CC=2)=C1 JHVSOYDRSVUHPP-QKPAOTATSA-N 0.000 description 2
- HCXHYLTZDQHASV-QKPAOTATSA-N (2r,3r,4s,5s)-2-[5-(4-chlorophenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C=2C=CC(Cl)=CC=2)=C1 HCXHYLTZDQHASV-QKPAOTATSA-N 0.000 description 2
- BTFGUBPVKWQDQC-BZZMCLGOSA-N (2r,3r,4s,5s)-2-[5-(4-methoxy-3-methylphenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound C1=C(C)C(OC)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](O)[C@H](O)CS2)O)=C1 BTFGUBPVKWQDQC-BZZMCLGOSA-N 0.000 description 2
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 2
- NMVDNZPJGGWNTM-UHFFFAOYSA-N (4-bromophenyl)-(3-hydroxypyridin-2-yl)methanone Chemical compound OC1=CC=CN=C1C(=O)C1=CC=C(Br)C=C1 NMVDNZPJGGWNTM-UHFFFAOYSA-N 0.000 description 2
- RVJPMWIIBKMWCR-UHFFFAOYSA-N (4-piperidin-1-ylphenyl)boronic acid Chemical compound C1=CC(B(O)O)=CC=C1N1CCCCC1 RVJPMWIIBKMWCR-UHFFFAOYSA-N 0.000 description 2
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 2
- PSPKFDYTJSJRFE-UHFFFAOYSA-N 1-(5-hydroxypyridin-3-yl)ethanone Chemical compound CC(=O)C1=CN=CC(O)=C1 PSPKFDYTJSJRFE-UHFFFAOYSA-N 0.000 description 2
- VMZSYLPRCQUKNJ-SASUGWTJSA-N 1-[3-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxypyridin-4-yl]ethanone Chemical compound CC(=O)C1=CC=NC=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)CS1 VMZSYLPRCQUKNJ-SASUGWTJSA-N 0.000 description 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 2
- ASJYKYYDHNKUAZ-YYIAUSFCSA-N 2-[5-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxypyridin-3-yl]benzonitrile Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C=2C(=CC=CC=2)C#N)=C1 ASJYKYYDHNKUAZ-YYIAUSFCSA-N 0.000 description 2
- WIJCOWWBPIEZMM-UHFFFAOYSA-N 2-chloro-3-fluoro-5-phenylmethoxypyridine Chemical compound N1=C(Cl)C(F)=CC(OCC=2C=CC=CC=2)=C1 WIJCOWWBPIEZMM-UHFFFAOYSA-N 0.000 description 2
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 2
- ZKROUVCCNIIVGK-UHFFFAOYSA-N 3-fluoro-2-phenyl-5-phenylmethoxypyridine Chemical compound C=1N=C(C=2C=CC=CC=2)C(F)=CC=1OCC1=CC=CC=C1 ZKROUVCCNIIVGK-UHFFFAOYSA-N 0.000 description 2
- LEWCRBUDCBNQSK-UHFFFAOYSA-N 3-methoxy-5-phenoxypyridine Chemical compound COC1=CN=CC(OC=2C=CC=CC=2)=C1 LEWCRBUDCBNQSK-UHFFFAOYSA-N 0.000 description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 2
- UPWIWQRQNIYYOJ-UHFFFAOYSA-N 4-(3-hydroxypyridin-2-yl)benzonitrile Chemical compound OC1=CC=CN=C1C1=CC=C(C#N)C=C1 UPWIWQRQNIYYOJ-UHFFFAOYSA-N 0.000 description 2
- VMSDNBJAEMADBX-UHFFFAOYSA-N 4-(5-hydroxypyridin-3-yl)benzonitrile Chemical compound OC1=CN=CC(C=2C=CC(=CC=2)C#N)=C1 VMSDNBJAEMADBX-UHFFFAOYSA-N 0.000 description 2
- XAGGWUYNAGQXNR-UHFFFAOYSA-N 4-(5-methoxypyridin-3-yl)benzonitrile Chemical compound COC1=CN=CC(C=2C=CC(=CC=2)C#N)=C1 XAGGWUYNAGQXNR-UHFFFAOYSA-N 0.000 description 2
- MUXCFQRUSUZQNW-VJUNAUMWSA-N 4-[3-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxypyridin-2-yl]benzonitrile Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CC=CN=C1C1=CC=C(C#N)C=C1 MUXCFQRUSUZQNW-VJUNAUMWSA-N 0.000 description 2
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 2
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 2
- SLLINPJLHURFNX-UHFFFAOYSA-N 5-bromo-2-fluoropyridin-3-ol Chemical compound OC1=CC(Br)=CN=C1F SLLINPJLHURFNX-UHFFFAOYSA-N 0.000 description 2
- IUHVLTLCNULIMA-UHFFFAOYSA-N 5-fluoro-6-phenylpyridin-3-ol Chemical compound FC1=CC(O)=CN=C1C1=CC=CC=C1 IUHVLTLCNULIMA-UHFFFAOYSA-N 0.000 description 2
- YSZJVVMCWVOLHW-UHFFFAOYSA-N 5-methylsulfonylpyridin-3-ol Chemical compound CS(=O)(=O)C1=CN=CC(O)=C1 YSZJVVMCWVOLHW-UHFFFAOYSA-N 0.000 description 2
- CHIZRFXFGYVCAS-UHFFFAOYSA-N 5-phenoxypyridin-3-ol Chemical compound OC1=CN=CC(OC=2C=CC=CC=2)=C1 CHIZRFXFGYVCAS-UHFFFAOYSA-N 0.000 description 2
- UVNPCRNIHOCXEA-UHFFFAOYSA-N 6-iodopyridin-3-ol Chemical compound OC1=CC=C(I)N=C1 UVNPCRNIHOCXEA-UHFFFAOYSA-N 0.000 description 2
- QPZAOKNWLYGWBF-UHFFFAOYSA-N 6-methylsulfanylpyridin-3-ol Chemical compound CSC1=CC=C(O)C=N1 QPZAOKNWLYGWBF-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- UIZWOIOQIRCZHR-XLNGHYISSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(6-methylsulfonylpyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=C(S(C)(=O)=O)N=C1 UIZWOIOQIRCZHR-XLNGHYISSA-N 0.000 description 2
- NXOOKRILVRMMHZ-OYYPCOLYSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[2-(4-methoxyphenyl)-4-methylpyridin-3-yl]oxythian-3-yl] acetate Chemical compound C1=CC(OC)=CC=C1C1=NC=CC(C)=C1O[C@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)CS1 NXOOKRILVRMMHZ-OYYPCOLYSA-N 0.000 description 2
- ZBBKHMAAQFZFIS-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[2-(4-methoxyphenyl)pyridin-4-yl]oxythian-3-yl] acetate Chemical compound C1=CC(OC)=CC=C1C1=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=CC=N1 ZBBKHMAAQFZFIS-KAOXLYBCSA-N 0.000 description 2
- AENCZKNVPJATGU-CIAFKFPVSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(2,4-difluorophenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C(=CC(F)=CC=2)F)=C1 AENCZKNVPJATGU-CIAFKFPVSA-N 0.000 description 2
- BSMYMXMGKCKBMR-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(3-cyanophenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=C(C=CC=2)C#N)=C1 BSMYMXMGKCKBMR-KAOXLYBCSA-N 0.000 description 2
- QTEJHFIISBAZHW-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(3-methoxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound COC1=CC=CC(C=2C=C(O[C@H]3[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS3)OC(C)=O)C=NC=2)=C1 QTEJHFIISBAZHW-KAOXLYBCSA-N 0.000 description 2
- UONSCBFSRWQBMF-UEQSERJNSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-cyano-3-methylphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=C(C)C(C#N)=CC=2)=C1 UONSCBFSRWQBMF-UEQSERJNSA-N 0.000 description 2
- WTRXDZKJCUWHPT-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-fluoro-2-methylphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C(=CC(F)=CC=2)C)=C1 WTRXDZKJCUWHPT-KAOXLYBCSA-N 0.000 description 2
- PPYVFHWOUPLIJT-RVFVQDDPSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-methoxy-3,5-dimethylphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound C1=C(C)C(OC)=C(C)C=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=C1 PPYVFHWOUPLIJT-RVFVQDDPSA-N 0.000 description 2
- YAZBZYQUMFHOEE-ZFFYZDHPSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-propan-2-yloxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound C1=CC(OC(C)C)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=C1 YAZBZYQUMFHOEE-ZFFYZDHPSA-N 0.000 description 2
- JNSBEPKGFVENFS-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC=C1C(F)(F)F JNSBEPKGFVENFS-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- KQIADDMXRMTWHZ-UHFFFAOYSA-N chloro-tri(propan-2-yl)silane Chemical compound CC(C)[Si](Cl)(C(C)C)C(C)C KQIADDMXRMTWHZ-UHFFFAOYSA-N 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- ZHOGHWVKKXUAPI-UHFFFAOYSA-N fluorooxy(phenyl)borinic acid Chemical compound FOB(O)C1=CC=CC=C1 ZHOGHWVKKXUAPI-UHFFFAOYSA-N 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- JRHPOFJADXHYBR-HTQZYQBOSA-N (1r,2r)-1-n,2-n-dimethylcyclohexane-1,2-diamine Chemical compound CN[C@@H]1CCCC[C@H]1NC JRHPOFJADXHYBR-HTQZYQBOSA-N 0.000 description 1
- HIWYFMBSFSTYGU-UHFFFAOYSA-N (2,3-difluoro-4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C(F)=C1F HIWYFMBSFSTYGU-UHFFFAOYSA-N 0.000 description 1
- QQLRSCZSKQTFGY-UHFFFAOYSA-N (2,4-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C=C1F QQLRSCZSKQTFGY-UHFFFAOYSA-N 0.000 description 1
- SQTUYFKNCCBFRR-UHFFFAOYSA-N (2,4-dimethoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C(OC)=C1 SQTUYFKNCCBFRR-UHFFFAOYSA-N 0.000 description 1
- LOCGPWGCRVKCFN-UHFFFAOYSA-N (2-chloro-4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C(Cl)=C1 LOCGPWGCRVKCFN-UHFFFAOYSA-N 0.000 description 1
- UKYCKUPXBPLXBA-UHFFFAOYSA-N (2-chloro-4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C(Cl)=C1 UKYCKUPXBPLXBA-UHFFFAOYSA-N 0.000 description 1
- NPLZNDDFVCGRAG-UHFFFAOYSA-N (2-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1C#N NPLZNDDFVCGRAG-UHFFFAOYSA-N 0.000 description 1
- IXDYORJWBXBHGC-UHFFFAOYSA-N (2-ethoxy-4-methylphenyl)boronic acid Chemical compound CCOC1=CC(C)=CC=C1B(O)O IXDYORJWBXBHGC-UHFFFAOYSA-N 0.000 description 1
- ZLODKAZZRDLUKX-UHFFFAOYSA-N (2-fluoro-5-methylphenyl)boronic acid Chemical compound CC1=CC=C(F)C(B(O)O)=C1 ZLODKAZZRDLUKX-UHFFFAOYSA-N 0.000 description 1
- QCSLIRFWJPOENV-UHFFFAOYSA-N (2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1F QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 1
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 1
- NSJVYHOPHZMZPN-UHFFFAOYSA-N (2-methylphenyl)boronic acid Chemical compound CC1=CC=CC=C1B(O)O NSJVYHOPHZMZPN-UHFFFAOYSA-N 0.000 description 1
- ALHSPUPUEAYEFU-MSQAHXEGSA-N (2r,3r,4s,5s)-2-(2-phenylpyridin-3-yl)oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CC=CN=C1C1=CC=CC=C1 ALHSPUPUEAYEFU-MSQAHXEGSA-N 0.000 description 1
- LLSMGOFVDOCGFI-SLBVQIDZSA-N (2r,3r,4s,5s)-2-(5-fluoro-6-phenylpyridin-3-yl)oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=C(C=2C=CC=CC=2)C(F)=C1 LLSMGOFVDOCGFI-SLBVQIDZSA-N 0.000 description 1
- HMZYOMHPQMYKCC-LMLFDSFASA-N (2r,3r,4s,5s)-2-(5-methylsulfonylpyridin-3-yl)oxythiane-3,4,5-triol Chemical compound CS(=O)(=O)C1=CN=CC(O[C@H]2[C@@H]([C@@H](O)[C@H](O)CS2)O)=C1 HMZYOMHPQMYKCC-LMLFDSFASA-N 0.000 description 1
- HQBULWHGBQOVRE-VJUNAUMWSA-N (2r,3r,4s,5s)-2-[2-(4-methoxyphenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound C1=CC(OC)=CC=C1C1=NC=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)CS1 HQBULWHGBQOVRE-VJUNAUMWSA-N 0.000 description 1
- VYONMQRCZZFXRQ-YYIAUSFCSA-N (2r,3r,4s,5s)-2-[5-(4-methoxyphenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound C1=CC(OC)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](O)[C@H](O)CS2)O)=C1 VYONMQRCZZFXRQ-YYIAUSFCSA-N 0.000 description 1
- ZHAMCKOMCBWHBL-QKPAOTATSA-N (2r,3r,4s,5s)-2-[5-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C=2C=CC(OC(F)(F)F)=CC=2)=C1 ZHAMCKOMCBWHBL-QKPAOTATSA-N 0.000 description 1
- AFZCAUOSBJMTFM-QKPAOTATSA-N (2r,3r,4s,5s)-2-[5-[4-(trifluoromethyl)phenyl]pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C=2C=CC(=CC=2)C(F)(F)F)=C1 AFZCAUOSBJMTFM-QKPAOTATSA-N 0.000 description 1
- VUCBZPQAPNUOJE-QKPAOTATSA-N (2r,3r,4s,5s)-2-[6-(4-fluorophenyl)pyridin-3-yl]oxythiane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CC=C(C=2C=CC(F)=CC=2)N=C1 VUCBZPQAPNUOJE-QKPAOTATSA-N 0.000 description 1
- RMGYQBHKEWWTOY-UHFFFAOYSA-N (3,4-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(F)=C1 RMGYQBHKEWWTOY-UHFFFAOYSA-N 0.000 description 1
- KDVZJKOYSOFXRV-UHFFFAOYSA-N (3,4-dimethylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1C KDVZJKOYSOFXRV-UHFFFAOYSA-N 0.000 description 1
- WJDZZXIDQYKVDG-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(Cl)=C1 WJDZZXIDQYKVDG-UHFFFAOYSA-N 0.000 description 1
- XDBHWPLGGBLUHH-UHFFFAOYSA-N (3-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C#N)=C1 XDBHWPLGGBLUHH-UHFFFAOYSA-N 0.000 description 1
- IILGLPAJXQMKGQ-UHFFFAOYSA-N (3-fluoro-4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1F IILGLPAJXQMKGQ-UHFFFAOYSA-N 0.000 description 1
- WPVBHUUZDFUIJA-UHFFFAOYSA-N (3-fluoro-4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1F WPVBHUUZDFUIJA-UHFFFAOYSA-N 0.000 description 1
- KNXQDJCZSVHEIW-UHFFFAOYSA-N (3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1 KNXQDJCZSVHEIW-UHFFFAOYSA-N 0.000 description 1
- LSEHTNHVLNXOKW-UHFFFAOYSA-N (3-hydroxypyridin-2-yl)-piperidin-1-ylmethanone Chemical compound OC1=CC=CN=C1C(=O)N1CCCCC1 LSEHTNHVLNXOKW-UHFFFAOYSA-N 0.000 description 1
- NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 1
- BJQCPCFFYBKRLM-UHFFFAOYSA-N (3-methylphenyl)boronic acid Chemical compound CC1=CC=CC(B(O)O)=C1 BJQCPCFFYBKRLM-UHFFFAOYSA-N 0.000 description 1
- IQMLIVUHMSIOQP-UHFFFAOYSA-N (4-fluoro-2-methylphenyl)boronic acid Chemical compound CC1=CC(F)=CC=C1B(O)O IQMLIVUHMSIOQP-UHFFFAOYSA-N 0.000 description 1
- AMSQNQJCBXQYEX-UHFFFAOYSA-N (4-methoxy-2-methylphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C(C)=C1 AMSQNQJCBXQYEX-UHFFFAOYSA-N 0.000 description 1
- BIWQNIMLAISTBV-UHFFFAOYSA-N (4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1 BIWQNIMLAISTBV-UHFFFAOYSA-N 0.000 description 1
- CJUHQADBFQRIMC-UHFFFAOYSA-N (4-propan-2-yloxyphenyl)boronic acid Chemical compound CC(C)OC1=CC=C(B(O)O)C=C1 CJUHQADBFQRIMC-UHFFFAOYSA-N 0.000 description 1
- YAXKWQSQZIVTFC-UHFFFAOYSA-N (5-bromo-2-fluoropyridin-3-yl)boronic acid Chemical compound OB(O)C1=CC(Br)=CN=C1F YAXKWQSQZIVTFC-UHFFFAOYSA-N 0.000 description 1
- VGXJJUFFRMKEKD-UHFFFAOYSA-N (5-hydroxypyridin-2-yl)-[4-(trifluoromethyl)phenyl]methanone Chemical compound N1=CC(O)=CC=C1C(=O)C1=CC=C(C(F)(F)F)C=C1 VGXJJUFFRMKEKD-UHFFFAOYSA-N 0.000 description 1
- 125000006823 (C1-C6) acyl group Chemical group 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- SWJPEBQEEAHIGZ-UHFFFAOYSA-N 1,4-dibromobenzene Chemical compound BrC1=CC=C(Br)C=C1 SWJPEBQEEAHIGZ-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- DYFSAZGSIBFUAI-UHFFFAOYSA-N 1-(3-hydroxypyridin-2-yl)ethanone Chemical compound CC(=O)C1=NC=CC=C1O DYFSAZGSIBFUAI-UHFFFAOYSA-N 0.000 description 1
- REYSBWKWFPSDDR-UHFFFAOYSA-N 1-(3-hydroxypyridin-4-yl)ethanone Chemical compound CC(=O)C1=CC=NC=C1O REYSBWKWFPSDDR-UHFFFAOYSA-N 0.000 description 1
- WESGRMTVUPBJHT-UHFFFAOYSA-N 1-(5-hydroxypyridin-2-yl)ethanone Chemical compound CC(=O)C1=CC=C(O)C=N1 WESGRMTVUPBJHT-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- WDQFQRKMOMOVSH-WRWGMCAJSA-N 1-[5-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxypyridin-2-yl]ethanone Chemical compound C1=NC(C(=O)C)=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)CS1 WDQFQRKMOMOVSH-WRWGMCAJSA-N 0.000 description 1
- XLQSXGGDTHANLN-UHFFFAOYSA-N 1-bromo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(Br)C=C1 XLQSXGGDTHANLN-UHFFFAOYSA-N 0.000 description 1
- UPQQXPKAYZYUKO-UHFFFAOYSA-N 2,2,2-trichloroacetamide Chemical compound OC(=N)C(Cl)(Cl)Cl UPQQXPKAYZYUKO-UHFFFAOYSA-N 0.000 description 1
- PZBSPSOGEVCRQI-UHFFFAOYSA-N 2-bromo-1,3,5-trifluorobenzene Chemical compound FC1=CC(F)=C(Br)C(F)=C1 PZBSPSOGEVCRQI-UHFFFAOYSA-N 0.000 description 1
- GGXSDQDNOMWAFV-UHFFFAOYSA-N 2-bromo-1h-pyridin-4-one Chemical compound BrC1=CC(=O)C=CN1 GGXSDQDNOMWAFV-UHFFFAOYSA-N 0.000 description 1
- PDOWLYNSFYZIQX-UHFFFAOYSA-N 2-bromo-3-methoxypyridine Chemical compound COC1=CC=CN=C1Br PDOWLYNSFYZIQX-UHFFFAOYSA-N 0.000 description 1
- MDHNVHCZDCSTMS-UHFFFAOYSA-N 2-bromo-5-fluorobenzonitrile Chemical compound FC1=CC=C(Br)C(C#N)=C1 MDHNVHCZDCSTMS-UHFFFAOYSA-N 0.000 description 1
- YKHQFTANTNMYPP-UHFFFAOYSA-N 2-bromopyridin-3-ol Chemical compound OC1=CC=CN=C1Br YKHQFTANTNMYPP-UHFFFAOYSA-N 0.000 description 1
- KLEQEGMDNINOTL-UHFFFAOYSA-N 2-chloro-4-methylpyridin-3-ol Chemical compound CC1=CC=NC(Cl)=C1O KLEQEGMDNINOTL-UHFFFAOYSA-N 0.000 description 1
- PTKTXYDJIOBEOD-UHFFFAOYSA-N 2-iodo-5-methoxypyridine Chemical compound COC1=CC=C(I)N=C1 PTKTXYDJIOBEOD-UHFFFAOYSA-N 0.000 description 1
- HRZOWBGCOJWHDY-UHFFFAOYSA-N 2-iodo-6-methylpyridin-3-ol Chemical compound CC1=CC=C(O)C(I)=N1 HRZOWBGCOJWHDY-UHFFFAOYSA-N 0.000 description 1
- LZMQEAWZBGDJCE-UHFFFAOYSA-N 2-methylsulfanylpyridin-3-ol Chemical compound CSC1=NC=CC=C1O LZMQEAWZBGDJCE-UHFFFAOYSA-N 0.000 description 1
- OUTRAZMEQDMUOK-UHFFFAOYSA-N 2-methylsulfonylpyridin-3-ol Chemical compound CS(=O)(=O)C1=NC=CC=C1O OUTRAZMEQDMUOK-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- RTKMFQOHBDVEBC-UHFFFAOYSA-N 3-bromo-3-buten-1-ol Chemical compound OCCC(Br)=C RTKMFQOHBDVEBC-UHFFFAOYSA-N 0.000 description 1
- FZWUIWQMJFAWJW-UHFFFAOYSA-N 3-bromo-5-methoxypyridine Chemical compound COC1=CN=CC(Br)=C1 FZWUIWQMJFAWJW-UHFFFAOYSA-N 0.000 description 1
- VIAAKVXECVQWOE-UHFFFAOYSA-N 3-bromo-5-phenoxypyridine Chemical compound BrC1=CN=CC(OC=2C=CC=CC=2)=C1 VIAAKVXECVQWOE-UHFFFAOYSA-N 0.000 description 1
- KNPSJINBUZCDRE-UHFFFAOYSA-N 3-hydroxy-n,n-dimethylpyridine-2-carboxamide Chemical compound CN(C)C(=O)C1=NC=CC=C1O KNPSJINBUZCDRE-UHFFFAOYSA-N 0.000 description 1
- XTVFTOVNAKNVQK-UHFFFAOYSA-N 3-hydroxypyridine-2-carbonitrile Chemical compound OC1=CC=CN=C1C#N XTVFTOVNAKNVQK-UHFFFAOYSA-N 0.000 description 1
- JGPYSOIVHGIKGD-UHFFFAOYSA-N 3-methoxy-5-methylsulfanylpyridine Chemical compound COC1=CN=CC(SC)=C1 JGPYSOIVHGIKGD-UHFFFAOYSA-N 0.000 description 1
- HMVHLVQMJNSVGB-UHFFFAOYSA-N 4-(5-hydroxypyridin-2-yl)benzonitrile Chemical compound N1=CC(O)=CC=C1C1=CC=C(C#N)C=C1 HMVHLVQMJNSVGB-UHFFFAOYSA-N 0.000 description 1
- PGBNGVBOKXSNCC-UHFFFAOYSA-N 4-(5-hydroxypyridin-2-yl)sulfanylbenzonitrile Chemical compound N1=CC(O)=CC=C1SC1=CC=C(C#N)C=C1 PGBNGVBOKXSNCC-UHFFFAOYSA-N 0.000 description 1
- RBRVPJRGYRRMCF-UHFFFAOYSA-N 4-(5-hydroxypyridin-2-yl)sulfonylbenzonitrile Chemical compound N1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(C#N)C=C1 RBRVPJRGYRRMCF-UHFFFAOYSA-N 0.000 description 1
- GYMSAMZENYGMBU-UHFFFAOYSA-N 4-(5-methoxypyridin-2-yl)benzonitrile Chemical compound N1=CC(OC)=CC=C1C1=CC=C(C#N)C=C1 GYMSAMZENYGMBU-UHFFFAOYSA-N 0.000 description 1
- 125000002999 4-(trifluoromethyl)benzoyl group Chemical group FC(C1=CC=C(C(=O)*)C=C1)(F)F 0.000 description 1
- AYQBMZNSJPVADT-UHFFFAOYSA-N 4-bromo-2-chlorobenzonitrile Chemical compound ClC1=CC(Br)=CC=C1C#N AYQBMZNSJPVADT-UHFFFAOYSA-N 0.000 description 1
- LPEBMDFRIKYFCF-UHFFFAOYSA-N 4-bromo-2-methylbenzonitrile Chemical compound CC1=CC(Br)=CC=C1C#N LPEBMDFRIKYFCF-UHFFFAOYSA-N 0.000 description 1
- SKXUZFJOLNNWIG-UHFFFAOYSA-N 4-bromo-3-methylbenzonitrile Chemical compound CC1=CC(C#N)=CC=C1Br SKXUZFJOLNNWIG-UHFFFAOYSA-N 0.000 description 1
- YCVSFCXUHPVAFH-UHFFFAOYSA-N 4-bromopyridin-3-ol Chemical compound OC1=CN=CC=C1Br YCVSFCXUHPVAFH-UHFFFAOYSA-N 0.000 description 1
- SEEUPVOHHNMWEG-UHFFFAOYSA-M 4-fluorobenzenesulfinate Chemical compound [O-]S(=O)C1=CC=C(F)C=C1 SEEUPVOHHNMWEG-UHFFFAOYSA-M 0.000 description 1
- OOHQHYJZUSXMFD-UHFFFAOYSA-N 4-iodobenzene-1,2-dicarbonitrile Chemical compound IC1=CC=C(C#N)C(C#N)=C1 OOHQHYJZUSXMFD-UHFFFAOYSA-N 0.000 description 1
- HKFQSXPNVJVXTO-UHFFFAOYSA-N 4-iodopyridin-3-ol Chemical compound OC1=CN=CC=C1I HKFQSXPNVJVXTO-UHFFFAOYSA-N 0.000 description 1
- MVPUXVBBHWUOFS-UHFFFAOYSA-N 4-sulfanylbenzonitrile Chemical compound SC1=CC=C(C#N)C=C1 MVPUXVBBHWUOFS-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- CDOQKISJPOWBKC-UHFFFAOYSA-N 5-bromo-1,3-difluoro-2-methoxybenzene Chemical compound COC1=C(F)C=C(Br)C=C1F CDOQKISJPOWBKC-UHFFFAOYSA-N 0.000 description 1
- VNYBIBSZZDAEOK-UHFFFAOYSA-N 5-bromopyridin-3-ol Chemical compound OC1=CN=CC(Br)=C1 VNYBIBSZZDAEOK-UHFFFAOYSA-N 0.000 description 1
- YUEKWNYGXNDQRO-UHFFFAOYSA-N 5-hydroxypyridine-2-carbonitrile Chemical compound OC1=CC=C(C#N)N=C1 YUEKWNYGXNDQRO-UHFFFAOYSA-N 0.000 description 1
- KAXIYYPIORYZLB-UHFFFAOYSA-N 5-hydroxypyridine-3-carbonitrile Chemical compound OC1=CN=CC(C#N)=C1 KAXIYYPIORYZLB-UHFFFAOYSA-N 0.000 description 1
- PXMCWDFORQZWQX-UHFFFAOYSA-N 5-methylsulfanylpyridin-3-ol Chemical compound CSC1=CN=CC(O)=C1 PXMCWDFORQZWQX-UHFFFAOYSA-N 0.000 description 1
- NUTMKQSGPRZCAU-UHFFFAOYSA-N 5-phenylpyridin-3-ol Chemical compound OC1=CN=CC(C=2C=CC=CC=2)=C1 NUTMKQSGPRZCAU-UHFFFAOYSA-N 0.000 description 1
- PTEFNEALEPSHLC-UHFFFAOYSA-N 6-bromopyridin-3-ol Chemical compound OC1=CC=C(Br)N=C1 PTEFNEALEPSHLC-UHFFFAOYSA-N 0.000 description 1
- VEHUGRIKMHCJLQ-UHFFFAOYSA-N 6-chloro-5-fluoropyridin-3-ol Chemical compound OC1=CN=C(Cl)C(F)=C1 VEHUGRIKMHCJLQ-UHFFFAOYSA-N 0.000 description 1
- BEMNZDZGBAGRAT-UHFFFAOYSA-N 6-methylsulfanylpyridin-3-amine Chemical compound CSC1=CC=C(N)C=N1 BEMNZDZGBAGRAT-UHFFFAOYSA-N 0.000 description 1
- RUZWYUXFBQWVLS-UHFFFAOYSA-N 6-methylsulfonylpyridin-3-ol Chemical compound CS(=O)(=O)C1=CC=C(O)C=N1 RUZWYUXFBQWVLS-UHFFFAOYSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- OXKLQCCVUIBPIA-UHFFFAOYSA-N C1=CC=C(C=C1)CN2C=C(C=CC2C(=O)O)O Chemical compound C1=CC=C(C=C1)CN2C=C(C=CC2C(=O)O)O OXKLQCCVUIBPIA-UHFFFAOYSA-N 0.000 description 1
- PNDBVOZKJCHPPJ-UHFFFAOYSA-N C1CNC(C1O)C(=O)C2=CC=C(C=C2)C#N Chemical compound C1CNC(C1O)C(=O)C2=CC=C(C=C2)C#N PNDBVOZKJCHPPJ-UHFFFAOYSA-N 0.000 description 1
- SXNYRDSHUMYMHQ-QXSJWSMHSA-N CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@H]1OC(=O)C)OC(=O)C)SC2=CC(=CN=C2)Br Chemical compound CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@H]1OC(=O)C)OC(=O)C)SC2=CC(=CN=C2)Br SXNYRDSHUMYMHQ-QXSJWSMHSA-N 0.000 description 1
- YROIZYKPQITBRP-UHFFFAOYSA-N COC1=CC(=CC(=C1)C2=CC=CC=N2)C#N Chemical compound COC1=CC(=CC(=C1)C2=CC=CC=N2)C#N YROIZYKPQITBRP-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 150000000901 D-xylose derivatives Chemical class 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 238000006994 Koenigs-Knorr glycosidation reaction Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- MVONPHIMPMYPPZ-SLBVQIDZSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(2-bromopyridin-4-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=NC(Br)=C1 MVONPHIMPMYPPZ-SLBVQIDZSA-N 0.000 description 1
- IEVPMNUGGBVDDV-DUFGSWQCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(2-chloro-4-methylpyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=C(C)C=CN=C1Cl IEVPMNUGGBVDDV-DUFGSWQCSA-N 0.000 description 1
- XUMFPMIUUWIGNW-HLPPOEQASA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(2-chloropyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=CN=C1Cl XUMFPMIUUWIGNW-HLPPOEQASA-N 0.000 description 1
- HLVYYVXWEJVKNX-XMTFNYHQSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(4-acetylpyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC=C1C(C)=O HLVYYVXWEJVKNX-XMTFNYHQSA-N 0.000 description 1
- OAEVBAIGZZEROK-HLPPOEQASA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(5-bromo-2-fluoropyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC(Br)=CN=C1F OAEVBAIGZZEROK-HLPPOEQASA-N 0.000 description 1
- VYMGVTWOJWCZQC-QKPAOTATSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-(5-iodopyridin-3-yl)oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(I)=C1 VYMGVTWOJWCZQC-QKPAOTATSA-N 0.000 description 1
- KFWGBASLZAEUEU-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[2-(4-fluoro-2-methylphenyl)pyridin-4-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=NC(C=2C(=CC(F)=CC=2)C)=C1 KFWGBASLZAEUEU-KAOXLYBCSA-N 0.000 description 1
- HJVSXCUDCNALJG-FVTFTPSCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[2-(4-fluorophenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=CN=C1C1=CC=C(F)C=C1 HJVSXCUDCNALJG-FVTFTPSCSA-N 0.000 description 1
- FFOPOAVUCHHZBU-CIAFKFPVSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[4-(4-fluorophenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC=C1C1=CC=C(F)C=C1 FFOPOAVUCHHZBU-CIAFKFPVSA-N 0.000 description 1
- FBZAMOWIZQMSHX-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[4-(4-methoxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound C1=CC(OC)=CC=C1C1=CC=NC=C1O[C@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)CS1 FBZAMOWIZQMSHX-KAOXLYBCSA-N 0.000 description 1
- ZQELPCXXMZWNMT-CIAFKFPVSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[4-[4-(trifluoromethyl)phenyl]pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC=C1C1=CC=C(C(F)(F)F)C=C1 ZQELPCXXMZWNMT-CIAFKFPVSA-N 0.000 description 1
- NBWWOSNBDHWPGN-CWKRKGSWSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(2,6-difluoro-4-methoxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound FC1=CC(OC)=CC(F)=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=C1 NBWWOSNBDHWPGN-CWKRKGSWSA-N 0.000 description 1
- CYHAYXRVDTXVHI-CIAFKFPVSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(2-chloro-4-fluorophenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C(=CC(F)=CC=2)Cl)=C1 CYHAYXRVDTXVHI-CIAFKFPVSA-N 0.000 description 1
- BFRJOFVCAYAKTK-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(2-chloro-4-methoxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound ClC1=CC(OC)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=C1 BFRJOFVCAYAKTK-KAOXLYBCSA-N 0.000 description 1
- NZXGINBQAGTJAO-UEQSERJNSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(3,4-dimethoxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound C1=C(OC)C(OC)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=C1 NZXGINBQAGTJAO-UEQSERJNSA-N 0.000 description 1
- RHOOGGRLOCOVMF-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(3-chloro-4-cyanophenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=C(Cl)C(C#N)=CC=2)=C1 RHOOGGRLOCOVMF-KAOXLYBCSA-N 0.000 description 1
- QPQNFAODLOENPY-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(3-chloro-4-methoxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound C1=C(Cl)C(OC)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=C1 QPQNFAODLOENPY-KAOXLYBCSA-N 0.000 description 1
- INGHZJNDLKUGIU-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(3-cyano-4-fluorophenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=C(C(F)=CC=2)C#N)=C1 INGHZJNDLKUGIU-KAOXLYBCSA-N 0.000 description 1
- MZJSFPKQKZZPBJ-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(3-fluoro-4-methoxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound C1=C(F)C(OC)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=C1 MZJSFPKQKZZPBJ-KAOXLYBCSA-N 0.000 description 1
- IIXGWXNIKRKWKD-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(3-fluoro-4-methylphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=C(F)C(C)=CC=2)=C1 IIXGWXNIKRKWKD-KAOXLYBCSA-N 0.000 description 1
- PLEJZVFDCLJNGO-UEQSERJNSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-cyano-2-methylphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C(=CC(=CC=2)C#N)C)=C1 PLEJZVFDCLJNGO-UEQSERJNSA-N 0.000 description 1
- CPPLNGWBEJZUQN-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-cyano-3-fluorophenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=C(F)C(C#N)=CC=2)=C1 CPPLNGWBEJZUQN-KAOXLYBCSA-N 0.000 description 1
- WIGHLLVNCDHJGG-ADYITMSISA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-cyanophenyl)-2-fluoropyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC(C=2C=CC(=CC=2)C#N)=CN=C1F WIGHLLVNCDHJGG-ADYITMSISA-N 0.000 description 1
- IUGVMLLOTAETJY-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-fluoro-2-methoxyphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound COC1=CC(F)=CC=C1C1=CN=CC(O[C@H]2[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)CS2)OC(C)=O)=C1 IUGVMLLOTAETJY-KAOXLYBCSA-N 0.000 description 1
- QNHFWXSIBQLWRC-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-fluoro-3-methylphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=C(C)C(F)=CC=2)=C1 QNHFWXSIBQLWRC-KAOXLYBCSA-N 0.000 description 1
- MZDIOTWLIYLZDF-CIAFKFPVSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-fluorophenyl)sulfonylpyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(S(=O)(=O)C=2C=CC(F)=CC=2)=C1 MZDIOTWLIYLZDF-CIAFKFPVSA-N 0.000 description 1
- VRPGTPWCTMSXNI-HVWQDESWSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-(4-piperidin-1-ylphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=CC(=CC=2)N2CCCCC2)=C1 VRPGTPWCTMSXNI-HVWQDESWSA-N 0.000 description 1
- DUAOQDXIBFYVPI-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-[4-(hydroxymethyl)phenyl]pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=CC(CO)=CC=2)=C1 DUAOQDXIBFYVPI-KAOXLYBCSA-N 0.000 description 1
- LHGATPGJUVDLQM-CIAFKFPVSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[5-[4-(trifluoromethyl)phenyl]pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CN=CC(C=2C=CC(=CC=2)C(F)(F)F)=C1 LHGATPGJUVDLQM-CIAFKFPVSA-N 0.000 description 1
- AKYRFCJAADXZMK-KAOXLYBCSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[6-(4-methylphenyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=C(C=2C=CC(C)=CC=2)N=C1 AKYRFCJAADXZMK-KAOXLYBCSA-N 0.000 description 1
- UHBXRSIYSXTATF-JTOYRKQZSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[6-(benzylcarbamoyl)pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=C(C(=O)NCC=2C=CC=CC=2)N=C1 UHBXRSIYSXTATF-JTOYRKQZSA-N 0.000 description 1
- UPEFSNVTDASPKW-CIAFKFPVSA-N [(3s,4s,5r,6r)-4,5-diacetyloxy-6-[6-[4-(trifluoromethyl)phenyl]pyridin-3-yl]oxythian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](OC(=O)C)CS[C@H]1OC1=CC=C(C=2C=CC(=CC=2)C(F)(F)F)N=C1 UPEFSNVTDASPKW-CIAFKFPVSA-N 0.000 description 1
- MWYPHOWMKHNMBH-LMLFDSFASA-N [(3s,4s,5r,6s)-4,5-diacetyloxy-6-bromothian-3-yl] acetate Chemical compound CC(=O)O[C@@H]1CS[C@@H](Br)[C@H](OC(C)=O)[C@H]1OC(C)=O MWYPHOWMKHNMBH-LMLFDSFASA-N 0.000 description 1
- PZRPBPMLSSNFOM-UHFFFAOYSA-N [4-(hydroxymethyl)phenyl]boronic acid Chemical compound OCC1=CC=C(B(O)O)C=C1 PZRPBPMLSSNFOM-UHFFFAOYSA-N 0.000 description 1
- XCNYCNXAQRXWAC-XLNGHYISSA-N [4-(trifluoromethyl)phenyl]-[5-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxypyridin-2-yl]methanone Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CC=C(C(=O)C=2C=CC(=CC=2)C(F)(F)F)N=C1 XCNYCNXAQRXWAC-XLNGHYISSA-N 0.000 description 1
- ALMFIOZYDASRRC-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)C=C1 ALMFIOZYDASRRC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000005189 alkyl hydroxy group Chemical group 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- JEHKKBHWRAXMCH-UHFFFAOYSA-N benzenesulfinic acid Chemical compound O[S@@](=O)C1=CC=CC=C1 JEHKKBHWRAXMCH-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YCOOQFCBEZGPIZ-UHFFFAOYSA-N bis(methylperoxy)-phenylborane Chemical compound COOB(OOC)C1=CC=CC=C1 YCOOQFCBEZGPIZ-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
- ZXZBMGGWHWRHPS-UHFFFAOYSA-N cyanato(phenyl)borinic acid Chemical compound N#COB(O)C1=CC=CC=C1 ZXZBMGGWHWRHPS-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- NLWIRIVYWMJDBX-UHFFFAOYSA-N cyclopenta-1,3-diene (3-diphenylphosphanylcyclopenta-1,4-dien-1-yl)-diphenylphosphane iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.c1c[c-](cc1P(c1ccccc1)c1ccccc1)P(c1ccccc1)c1ccccc1 NLWIRIVYWMJDBX-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- IMBKASBLAKCLEM-UHFFFAOYSA-L ferrous ammonium sulfate (anhydrous) Chemical compound [NH4+].[NH4+].[Fe+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O IMBKASBLAKCLEM-UHFFFAOYSA-L 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- SUHCFIAVQXYETN-UHFFFAOYSA-N hydroxymethoxy(phenyl)borinic acid Chemical compound OCOB(O)C1=CC=CC=C1 SUHCFIAVQXYETN-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 150000002576 ketones Chemical group 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940075610 mercuric cyanide Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- KNPNGMXRGITFLE-UHFFFAOYSA-N methylperoxy(phenyl)borinic acid Chemical compound COOB(O)C1=CC=CC=C1 KNPNGMXRGITFLE-UHFFFAOYSA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
- OFCCYDUUBNUJIB-UHFFFAOYSA-N n,n-diethylcarbamoyl chloride Chemical compound CCN(CC)C(Cl)=O OFCCYDUUBNUJIB-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- QQKAFSAAAWJEFA-KYHPRHEASA-N n-benzyl-5-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxypyridine-2-carboxamide Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CC=C(C(=O)NCC=2C=CC=CC=2)N=C1 QQKAFSAAAWJEFA-KYHPRHEASA-N 0.000 description 1
- WVHYDIXAPOIZNT-KYHPRHEASA-N n-benzyl-5-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxypyridine-3-carboxamide Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CS[C@H]1OC1=CN=CC(C(=O)NCC=2C=CC=CC=2)=C1 WVHYDIXAPOIZNT-KYHPRHEASA-N 0.000 description 1
- DTUDWOKMMFITJJ-UHFFFAOYSA-N n-benzyl-5-hydroxypyridine-2-carboxamide Chemical compound N1=CC(O)=CC=C1C(=O)NCC1=CC=CC=C1 DTUDWOKMMFITJJ-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 125000003132 pyranosyl group Chemical group 0.000 description 1
- UMLDUMMLRZFROX-UHFFFAOYSA-N pyridin-2-ylboronic acid Chemical class OB(O)C1=CC=CC=N1 UMLDUMMLRZFROX-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 description 1
- SUGXYMLKALUNIU-UHFFFAOYSA-N silver;imidazol-3-ide Chemical compound [Ag+].C1=C[N-]C=N1 SUGXYMLKALUNIU-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Definitions
- the present invention relates to novel 5-thioxylose compounds, preferably 5-thioxylopyranose derivatives, as well as to a process for their preparation and their use as active principle of medicaments, in particular for the treatment or prevention of thromboses.
- D-xylose Derivatives of D-xylose are already known, for example in EP 051 023 B1, US 4,877,808, EP 421,829 B1 or in J. Med. Chem. Flight. 36, No. 7, p 898-903.
- the compounds described in these documents are useful for reducing the risk of venous thrombosis in humans.
- the mechanism of action of these compounds appears to be an effect on plasma glycosaminoglycans (J. Biol Chem., Vol 270 No. 6, pp 2662-68, Thromb Haemost, 1999, 81, 945-950).
- the new compounds according to the invention are characterized in that they are chosen from: a) compounds of formula:
- the pentapyranosyl group represents a free or acylated 5-thio- ⁇ -D-xylopyranosyl group, R represents a hydrogen atom or a C 2 -C e acyl group;
- - R represents a C 1 -C 4 alkylsulfonyl group, a C 2 -C 6 acyl group, a CONR 'R "group, or a group
- X represents a single bond, an oxygen atom, a sulfoxy group, a -CO- group or a -CHOH- group, and
- Ra represents a hydrogen atom, a halogen, a hydroxyl group, a C 1 -C 4 alkyl group , a trifluoromethyl group, a trifluoromethoxy group, a cyano group, a C 1 -C 4 hydroxyalkyl group, an acyl group, C 2 -C 4 alkoxy, Ci-C 4, a group NR'R ",
- Rb and Rc each independently represent a hydrogen atom, a halogen atom, a C 1 -C 4 alkyl group, a cyano group, a C 1 -C 4 alkoxy group, - R 2 represents a hydrogen atom, a C 1 -C 4 alkyl group or a halogen atom,
- R 'and R each independently represent a hydrogen atom or a C1-C4 alkyl group , optionally substituted by an aromatic ring, or together with the nitrogen atom to which they are attached form a ring having 5 or 6 carbon atoms, b) their addition salts, c) their active metabolites.
- the invention also relates to the compounds of formula I for use as a pharmacologically active substance.
- the invention relates to the use of at least one substance chosen from the compounds of formula I and their non-toxic salts for the preparation of a medicament, useful in human or animal therapy, for prevention or treatment thromboses, especially thromboses Venous.
- the compounds according to the invention being active according to a mode of action involving glycosaminoglycans, they may be useful as an active principle of a medicament for the treatment or prevention of any other disease in which glycosaminoglycans are involved.
- C 1 -C 4 alkyl group means a linear, branched or cyclized hydrocarbon chain containing from 1 to 4 carbon atoms.
- C 1 -C 4 alkyl groups include methyl, ethyl, propyl, butyl, 1-methylethyl, 1,1-dimethylethyl, 1-methylpropyl,
- alkyl group optionally substituted with an aromatic ring is meant for example a phenylmethyl (benzyl) or phenylethyl group.
- halogen it is necessary to include a fluorine, chlorine, bromine or iodine atom, and preferably a fluorine or chlorine atom.
- C 2 -C 6 acyl group is meant acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, as well as their homologues in which the chain may be branched.
- C 1 -C 4 alkoxy group means a linear, branched or cyclized hydrocarbon chain having from 1 to 4 carbon atoms bonded by an oxygen atom.
- C 1 -C 4 alkoxy groups mention may be made of methoxy, ethoxy, propoxy, butoxy, 1-methylethoxy and 1,1-dimethylethoxy groups.
- Additional salts means the addition salts obtained by reaction of a compound of formula I with a mineral or organic acid. Preferably, these are pharmaceutically acceptable addition salts.
- the hydrates or solvates of the compounds of formula I or the salts of the compounds of formula I are also an integral part of the invention.
- mineral acids suitable for salifying a basic compound of formula I hydrochloric, hydrobromic, phosphoric and sulfuric acids are preferred.
- organic acids suitable for salifying a compound Basic of formula I methanesulfonic, benzenesulfonic, toluenesulfonic, maleic, fumaric, oxalic, citric, tartaric, lactic and trifluoroacetic acids are preferred.
- Active metabolites are those compounds produced in the biological medium from the compounds of formula I and which possess a pharmacological activity of the same nature as the compounds of formula I described in the present application.
- the compounds of formula I in which R 1 represents an acyl group may be metabolized by reduction of the ketone function depending on alcohol (-CHOH-) to provide a new compound (metabolite) which retains pharmacological activity as well. nature than that of the compounds of formula I.
- R 1 represents a phenyl group optionally substituted by the groups Ra, Rb and Rc, as defined above, are particularly preferred.
- the compounds of formula I according to the invention can be prepared by implementing the glycosylation methods known to those skilled in the art, in particular: a) the method of HELFERICH described in the book “The Carbohydrate, Chemistry and Biochemistry", 2nd edition, Academic Press, New York-London, 1972, Volume IA pages 292-294, by condensation of a peracetylated sugar with an aromatic hydroxyheterocycle in the presence of a Lewis acid; b) the method of KOENIGS-KNORR (idem, pages 295-299) by condensation of a halogenated acylose with a phenolic hydroxy group in the presence of a proton acceptor, such as mercuric cyanide, imidazolate of silver or silver trifluoromethylsulfonate.
- a proton acceptor such as mercuric cyanide, imidazolate of silver or silver trifluoromethylsulfonate.
- the compounds of formula I are preferably prepared according to methods derived from the methods referenced above.
- - Ri represents a C 1 -C 4 alkylsulfonyl group, a C 2 -C 6 acyl group, a CONR'R '' group, or a group
- X represents a single bond, an oxygen atom, a sulphoxy group, a -CO- group or a -CHOH- group
- - Ra represents a hydrogen atom, a halogen, an alkyl group or
- Ci-C 4 trifluoromethyl, trifluoromethoxy, cyano, hydroxyalkyl
- Rb and Rc are each independently of the other a hydrogen atom, a halogen atom, an alkyl group Ci-C 4, a cyano group, an alkoxy group-C 4,
- R 2 represents a hydrogen atom, a C 1 -C 4 alkyl group or a halogen atom
- R 'and R each independently represent a hydrogen atom or a C 1 -C 4 alkyl group, optionally substituted by an aromatic ring, or form together with the nitrogen atom to which they are attached a ring having 5 or 6 carbon atoms,
- Hal represents a halogen, preferably bromine and R represents a C 2 -C 6 acyl group, preferentially the acetyl group, in an aprotic solvent such as acetonitrile or toluene, in the presence of a silver salt; , in particular silver oxide or imidazolate or a zinc salt (in particular oxide or chloride) in an anhydrous medium, at a temperature of between 25 and 110 ° C. and for 1 to 10 hours, for obtain the compound of formula:
- R, R 1, R 2 retain the same meaning as in the starting compounds; b) if necessary, reacting the compound of formula I obtained above with a solution of ammonia in methanol to perform the deaylation and thus replace the acyl group with hydrogen atoms and obtain the compound of formula: wherein R 1 and R 2 retain the same meaning as above; c) if necessary, reacting one of the compounds I or Ia obtained above with an acid according to methods known to those skilled in the art to obtain the corresponding addition salt.
- the replacement of the acyl group by a hydrogen atom can be carried out by the action of a metal alkoxide, preferentially sodium methylate in a catalytic amount, in methanol, at a temperature of temperature between 0 and 30 0 C and for 0.5 to 2 hours to obtain the compound of formula Ia from the compound of formula I wherein R represents a C 2 -C 6 acyl group.
- a metal alkoxide preferentially sodium methylate in a catalytic amount, in methanol
- the compounds of formula I can be obtained by the action of tetra-O-acetyl-5-thioxylopyranose of formula:
- R 1 represents a C 1 -C 4 alkylsulfonyl group, a C 1 -C 6 acyl group, a CONR'R "group, or a group
- X represents a single bond, an oxygen atom, a sulfoxy group, a -CO- group or a -CHOH- group
- - Ra represents a hydrogen atom, a halogen, an alkyl group or
- Ci-C 4 trifluoromethyl, trifluoromethoxy, cyano, alkyl hydroxy, C 1 -C 4 acyl, C 2 -C 4 alkoxy Ci-C4, NR 'R',
- Rb and Rc each independently represent a hydrogen atom, a halogen atom, a C 1 -C 4 alkyl group, a cyano group, a C 1 -C 4 alkoxy group,
- R 2 represents a hydrogen atom, a C 1 -C 4 alkyl group or a halogen atom
- R 'and R each independently represent a hydrogen atom or a C1-C4 alkyl group , optionally substituted by an aromatic ring, or together with the nitrogen atom to which they are attached form a ring having 5 or 6 carbon atoms in an aprotic solvent, such as, for example, dichloromethane, in the presence of a Lewis acid type catalyst, for example tin tetrachloride, at a temperature of between 20 and 60 ° C. and for 1 at 2 hours, to obtain the compound of formula:
- the compounds of formula I can be obtained by reacting a thioxylose derivative of formula:
- R 1 represents a C 1 -C 4 alkylsulfonyl group, a C 2 -C 6 acyl group, a CONR 'R "group, or a group
- - X represents a single bond, an oxygen atom, a sulfoxy group, a -CO- group or a -CHOH- group
- Ra represents a hydrogen atom, a halogen, a C 1 -C 4 alkyl group, a trifluoromethyl group, a trifluoromethoxy group, a cyano group, a C 1 -C 4 hydroxyalkyl group or a C 2 -C 4 acyl group; 4 alkoxy, Ci-C 4, NR 'R ",
- Rb and Rc each independently represent a hydrogen atom, a halogen atom, a C 1 -C 4 alkyl group, a cyano group, a C 1 -C 4 alkoxy group
- R 2 represents a hydrogen atom, a C 1 -C 4 alkyl group or a halogen atom
- R 'and R each independently represent a hydrogen atom or a C 1 -C 4 alkyl group optionally substituted by an aromatic ring, or together with the nitrogen atom to which they are attached form a ring having 5 or 6 carbon atoms, in an aprotic solvent, such as dichloromethane, in the presence of a catalyst such as trimethylsilyl trifluoromethanesulfonate, at a temperature between -25 ° C and room temperature and for 1 to 5 hours to obtain the thioxylopyranoside of formula:
- - Ra represents a hydrogen atom, a halogen, a hydroxyl group, alkyl C 1 -C 4 alkyl, trifluoromethyl, trifluoromethoxy, cyano, hydroxyalkyl Ci -C 4 alkyl, an acyl group of C 2 -C 4 alkoxy, Ci-C 4, NR 'R ",
- Rb and Rc each independently represent a hydrogen atom, a halogen atom, a C 1 -C 4 alkyl group, a cyano group, a C 1 -C 4 alkoxy group,
- R 'and R each independently represent a hydrogen atom or a C1-C4 alkyl group , optionally substituted by an aromatic ring, or together with the nitrogen atom to which they are attached form a ring having 5 or 6 carbon atoms,
- - R "'represents a hydrogen atom or an alkyl group Ci-C 4. in the presence of a palladium catalyst such as [1,1-bisdiphényl- phosphinoferrocènejdichloropalladium dichloromethane, a palladium catalyst immobilized on resin or the Herrmann catalyst, a solvent polar protic such as methanol, and cesium fluoride or sodium carbonate or other mineral bases optionally supplemented with lithium chloride, at a temperature of between 70 ° C. and 150 ° C. for 5 minutes to 72 hours at room temperature. microwave aid or a conventional heating method, to obtain the compound of formula:
- a palladium catalyst such as [1,1-bisdiphényl- phosphinoferrocènejdichloropalladium dichloromethane
- a palladium catalyst immobilized on resin or the Herrmann catalyst a solvent polar protic such as methanol, and cesium fluoride or sodium carbonate or other mineral bases
- Ra, Rb, Rc, R and R 2 retain the same meaning as in the starting materials.
- another similar method consists in reacting a glycosylated pyridinylboronate of formula:
- Ra, Rb, Rc, R and R 2 retain the same meaning as in the starting materials.
- glycosylation reactions described above most often lead to a mixture of isomers of ⁇ and ⁇ configuration and it is generally necessary to optimize the operating conditions in order to obtain favorable proportions for the ⁇ -configuration isomer. For the same reason, it may also be necessary to carry out purifications either by recrystallization or by chromatography to obtain the pure ⁇ isomer.
- DME refers to dimethoxethane Preparation 1: (4-bromophenyl) (3-hydroxy-2-pyridinyl) methanone
- the neutralized mixture is extracted with dichloromethane; the organic phase is dried over magnesium sulfate. After evaporation of the solvent, the expected product is obtained in the form of a yellow solid with a yield of 35%. M.p. 94-95 ° C.
- the medium is brought to neutral pH by washing with saturated sodium bicarbonate solution, extracted with ethyl acetate and dried over magnesium sulfate. After purification by chromatography on silica gel (eluent: toluene / ethyl acetate 8/2, then pure ethyl acetate and finally ethyl acetate / ammonia 95/5, v / v), the expected product is obtained under form of a pale pink solid with a yield of 66%. F> 260 0 C.
- a mixture of 1.82 g (8.65 mM) of the compound obtained according to Preparation 4 and 6 g (52 mM) of pyridinium hydrochloride are heated at 160 ° C. for 3 h 30 min.
- the mixture is then cooled to room temperature, taken up with 100 ml of water, adjusted to pH 7 and extracted with ethyl acetate.
- the organic phase is washed with water and then with a saturated solution of sodium chloride, and dried over magnesium sulfate.
- the product is purified by chromatography on a silica column (eluent: dichloromethane / ethanol 99/1, v / v) and the expected product is obtained in the form of a white powder with a yield of 53%.
- a solution of 0.9 g (3.6 mM) of 3-bromo-5-phenoxypyridine in 2 ml of methanol is prepared in a microwave tube.
- 8 ml (8 mM) of a solution of 1 M sodium methoxide in methanol and 0.252 g (4 mM) of powdered copper are added.
- the tube is closed and the reaction mixture is heated with microwaves at 150 ° C. for one hour, then filtered and concentrated under reduced pressure.
- the concentration residue is taken up in water and extracted with dichloromethane.
- the organic phase is washed with water, dried over sodium sulphate and concentrated under reduced pressure.
- Preparation 18 2-phenyl-3-fluoro-5- (phenylmethoxy) pyridine 6.8 g (28.6 mM) of 2-chloro-3-fluoro-5- (phenylmethoxy) pyridine and 110 ml of DME are mixed and 4.18 g (34 mM) phenylboronic acid. 6.64 g (156 mM) of lithium chloride and 1.65 g (1.4 mM) of tetrakis (triphenylphosphine) palladium are added. Finally, 38 ml (76 mM) of a 2M potassium carbonate solution are added and refluxed for 18 hours.
- a solution of 1.36 g (6.18 mM) of 5-bromo-2-fluoro-3-pyridineboronic acid is prepared in a mixture of 9.5 ml of ethanol, 2.3 ml of acetic acid and 1.3 ml of ethyl acetate.
- To the solution is added 2.2 ml of 30% hydrogen peroxide.
- the reaction mixture is stirred at a temperature of 35 ° C for 3 hours, then cooled and extracted with ethyl ether.
- the organic phases are washed with a ferrous ammonium sulphate solution, dried over magnesium sulphate, filtered and concentrated under reduced pressure.
- Preparation 23 5-bromo-3-pyridinyl 2.3> 4-tri-0-acetyl-5-thio- ⁇ -D-xylopyranoside
- the mixture is heated at 150 ° C. for 15 minutes using microwaves. After cooling, the reaction medium is filtered and concentrated under reduced pressure.
- the evaporation residue is taken up in methylene chloride and a 5N sodium hydroxide solution.
- the combined aqueous phases are neutralized, in the cold state, with a concentrated hydrochloric acid solution (10N), and then extracted. with ethyl acetate.
- the organic phase is dried over magnesium sulfate, filtered and concentrated under reduced pressure.
- the evaporation residue is purified by chromatography on silica gel, eluting with pure dichloromethane and then with a dichloromethane / methanol mixture (9/1, v / v).
- the product is purified by chromatography on silica gel, eluting with a toluene / isopropanol mixture (98/2, v / v).
- the purified product is crystallized in isopropyl alcohol.
- the product is purified by chromatography on a silica column, eluting with a cyclohexane / ethyl acetate mixture (6/4, v / v).
- the expected product is obtained in the form of a yellow solid, with a yield of 40%.
- Example 13 5-phenyl-3-pyridinyl 2,3 ? 4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside
- the expected product is obtained in the form of a white solid.
- Example 17 6 - [(4-Eyanophenyl) sulfonyl] -3-pyridinyl 2,3 ? 4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 18 6 - [(4-cyanophenyl) sulfonyl] -3-pyridinyl-5-thio- ⁇ -D-xylopyranoside
- the reaction medium is then filtered through a Watman filter, rinsed with ethyl acetate and extracted.
- the pH is neutralized with an ammonium chloride solution.
- the organic phase is dried over sodium sulfate and the product is concentrated under reduced pressure.
- the product is purified by chromatography on a silica column (eluent: dichloromethane / ethyl acetate 99/1, v / v) and the expected product is obtained in the form of a white powder with a yield of 90%.
- a solution of 0.55 g (1.11 mM) of 4-iodo-3-pyridinyl 2,3,4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside is prepared in 3 ml of DME and a solution of 0.176 g (1.66 mM) of sodium carbonate in 2.5 ml of water, 0.091 g (0.11 mM) of [1,1'-bis (diphenylphosphino) ferrocene] -dichloropalladium ( ⁇ ) - dichloromethane and 0.326 g (2.2 mM) of 4-cyano-phenylboronic acid.
- the reaction mixture is heated with microwaves at 90 ° C.
- reaction mixture is filtered, the filtrate is taken up in 20 ml of ethyl acetate, the organic phase is washed with 1N sodium hydroxide solution, dried over magnesium sulphate and concentrated under reduced pressure to give the expected product under form of a pale yellow solid with a yield of 0.7%.
- the reaction mixture is filtered, rinsed with methanol and the organic phases are concentrated.
- the product is purified by chromatography on a silica column (eluent: dichloromethane / ethyl acetate 98/2 then 70/30, v / v) and the expected product is obtained in the form of a cream powder with a yield of 80%. . M.p. 156 ° C.
- Example 53 5- [4- (trifluoromethyl) phenyl] -3-pyridinyl 2.3 "4-tri-O-acetyl-5-thio- ⁇ -D-xylo-pyranoside and 5- [4- (trifluoromethyl) phenyl ] -3-pyridinyl 5-thio- ⁇ -D-xylopyranoside
- Example 54 5- (3-cyanophenyl) -3-pyridinyl 2,3,4-tri-O -acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 68 5- [4- (1-Methylethoxy) phenyl] -3-pyridinyl 2,3,4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 90 5- (4-cyano-3-fluorophenyl) -3-pyridinyl 2,3,4-tri-O -etetyl-5-thio- ⁇ -D-xylopyranoside
- Example 100 4- (4-methoxyphenyl) -3-pyridinyl 2,3 ? 4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 102 5- (3-Fluoro-4-methoxyphenyl) -3-pyridinyl 2,3,4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 104
- Example 106 5- (3-Fluoro-4-methylphenyl) -3-pyridinyl 2,3,4-tri-O -acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 108 5- (3,4-dimethylphenyl) -3-pyridinyl 5 2,3-4-tri-0-acetyl-5-thio- ⁇ -D-xylo-pyranoside
- Example 110
- Example 112 5- (2-ehloro-4-methoxyphenyl) -3-pyridinyl 2.3> 4-tri-0-acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 141 5 - [(4-fluorophenyl) sulfonyl] -3-pyridinyl 2,3 ) 4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 151
- Example 155 5- (3,4-dieyanophényl) -3-pyridinyl 2.3> 4-tri-0-acetyl-5-thio- ⁇ -D-xylo-pyranoside
- Example 156 5- (3,4-dicyanophenyl) -3-pyridinyl-5-thio- ⁇ -D-xylopyranoside
- Example 158 6- [4- (1-Piperidinyl) phenyl] -3-pyridinyl-5-thio- ⁇ -D-xylopyranoside
- Example 159 5 - [(1H-N-diethylamino) carbonyl] -3-pyridinyl 2,3,4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside
- Example 143 The procedure is analogous to the first part of Example 143, starting from 5-bromo-3-pyridinyl 2,3,4-tri-O-acetyl-5-thio- ⁇ -D-xylopyranoside and bispinacolborane. After filtering and evaporating the reaction mixture, the residue is extracted with ethyl acetate and washed with water.
- Example 160 5 - [(1H- ⁇ -Diethylamino) carbonyl] -3-pyridyl-5-thio- ⁇ -D-xylopyranoside
- Example 159 By following a procedure analogous to Example 6, starting from the product obtained in Example 159, there is obtained 5 - [(N -V-diethylamino) carbonyl] -3-pyridinyl-5-thio- ⁇ -D-xylopyranoside. in the form of a beige solid with a yield of 59%.
- Mp 143 ° C (crystallized from water).
- the subject of the present invention is therefore a compound of formula (I) according to the invention as well as its salts with a pharmaceutically acceptable acid, solvates and hydrates for their use as a medicament.
- the compound of formula (I) or a pharmaceutically acceptable salt, solvate or hydrate thereof may be used for the preparation of an antithrombotic medicament intended, in particular, for the treatment or prevention of disorders of the venous circulation and especially for to correct certain haematological parameters sensitive to the venous level, or to compensate for heart failure.
- the present invention therefore also relates to pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt, solvate or hydrate thereof.
- These pharmaceutical compositions usually contain suitable excipients. Said excipients are chosen according to the pharmaceutical form and the mode of administration desired, in particular oral or injectable.
- compositions are prepared according to conventional methods well known to those skilled in the art.
- the compounds according to the invention can be formulated with physiologically acceptable excipients to obtain an injectable form to be used directly, an injectable form to be prepared extemporaneously or a solid form for oral administration such as, for example, a capsule or a tablet.
- an injectable form may preferably be prepared by lyophilization of a filtered and sterilized solution containing the compound according to the invention and a soluble excipient in an amount necessary and sufficient to obtain an isotonic solution after extemporaneous addition of water. for injection.
- the resulting solution may be administered either in a single subcutaneous or intramuscular injection or as a slow infusion.
- each unit dose may contain 10 to 500 mg of at least one compound according to the invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0502978A FR2883561B1 (fr) | 2005-03-25 | 2005-03-25 | Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique |
PCT/FR2006/050259 WO2006100413A2 (fr) | 2005-03-25 | 2006-03-24 | Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1861411A2 true EP1861411A2 (fr) | 2007-12-05 |
Family
ID=34955178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06726275A Withdrawn EP1861411A2 (fr) | 2005-03-25 | 2006-03-24 | Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique |
Country Status (18)
Country | Link |
---|---|
US (1) | US8148407B2 (fr) |
EP (1) | EP1861411A2 (fr) |
JP (1) | JP5036698B2 (fr) |
KR (1) | KR101336547B1 (fr) |
CN (1) | CN101146817B (fr) |
AU (1) | AU2006226251B2 (fr) |
BR (1) | BRPI0609211A2 (fr) |
CA (1) | CA2602698A1 (fr) |
FR (1) | FR2883561B1 (fr) |
IL (1) | IL185691A (fr) |
MA (1) | MA29372B1 (fr) |
MX (1) | MX2007011849A (fr) |
NO (1) | NO20074609L (fr) |
RU (1) | RU2412195C2 (fr) |
TN (1) | TNSN07362A1 (fr) |
UA (1) | UA92908C2 (fr) |
WO (1) | WO2006100413A2 (fr) |
ZA (1) | ZA200707947B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2906248B1 (fr) * | 2006-09-27 | 2008-12-26 | Fournier S A Sa Lab | Nouveaux derives de 5-thioxylopyranose |
CN113527536B (zh) * | 2020-04-21 | 2024-03-22 | 杭州德柯医疗科技有限公司 | 一种含氟多糖高分子化合物及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2614893B1 (fr) * | 1987-05-04 | 1989-12-22 | Fournier Innovation Synergie | Nouveaux b-d-phenyl-thioxylosides, leur procede de preparation et leur application en therapeutique |
US5246961A (en) * | 1988-10-18 | 1993-09-21 | Fournier Industrie Et Sante | β-d-phenylthioxylosides, and their use as therapeutic agents |
IE63544B1 (en) * | 1988-10-18 | 1995-05-17 | Fournier Ind & Sante | Novel Beta-d-phenylthioxylosides their method of preparation and their use in therapy |
ATE92074T1 (de) * | 1988-11-03 | 1993-08-15 | Fournier Ind & Sante | Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |
JPH0753747B2 (ja) * | 1988-11-03 | 1995-06-07 | フルニエ アンデュストリ エ サンテ | β―D―フェニルチオキシロシド、その調製方法および薬剤としての使用 |
FR2660313B1 (fr) * | 1990-04-02 | 1992-07-03 | Fournier Ind & Sante | Nouveau sulfonyl-phenyl-betha-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique. |
FR2801055B1 (fr) * | 1999-11-17 | 2002-02-08 | Fournier Ind & Sante | Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique |
EP1609799A4 (fr) * | 2003-04-01 | 2008-10-29 | Taisho Pharmaceutical Co Ltd | Derives heteroaryle 5-thio-beta-d-glucopyranoside et medicaments contre le diabete contenant ces derives |
FR2860234B1 (fr) | 2003-09-25 | 2005-12-23 | Fournier Lab Sa | Nouveaux derives 666 du thioxylose |
-
2005
- 2005-03-25 FR FR0502978A patent/FR2883561B1/fr not_active Expired - Fee Related
-
2006
- 2006-03-24 KR KR1020077021135A patent/KR101336547B1/ko not_active IP Right Cessation
- 2006-03-24 WO PCT/FR2006/050259 patent/WO2006100413A2/fr active Application Filing
- 2006-03-24 RU RU2007135251/04A patent/RU2412195C2/ru not_active IP Right Cessation
- 2006-03-24 US US11/909,489 patent/US8148407B2/en not_active Expired - Fee Related
- 2006-03-24 UA UAA200710643A patent/UA92908C2/ru unknown
- 2006-03-24 AU AU2006226251A patent/AU2006226251B2/en not_active Ceased
- 2006-03-24 ZA ZA200707947A patent/ZA200707947B/xx unknown
- 2006-03-24 BR BRPI0609211-0A patent/BRPI0609211A2/pt not_active IP Right Cessation
- 2006-03-24 EP EP06726275A patent/EP1861411A2/fr not_active Withdrawn
- 2006-03-24 CA CA002602698A patent/CA2602698A1/fr not_active Abandoned
- 2006-03-24 CN CN200680009678XA patent/CN101146817B/zh not_active Expired - Fee Related
- 2006-03-24 MX MX2007011849A patent/MX2007011849A/es active IP Right Grant
- 2006-03-24 JP JP2008502445A patent/JP5036698B2/ja not_active Expired - Fee Related
-
2007
- 2007-09-03 IL IL185691A patent/IL185691A/en not_active IP Right Cessation
- 2007-09-12 NO NO20074609A patent/NO20074609L/no not_active Application Discontinuation
- 2007-09-20 MA MA30229A patent/MA29372B1/fr unknown
- 2007-09-24 TN TNP2007000362A patent/TNSN07362A1/fr unknown
Non-Patent Citations (1)
Title |
---|
See references of WO2006100413A2 * |
Also Published As
Publication number | Publication date |
---|---|
ZA200707947B (en) | 2008-12-31 |
RU2007135251A (ru) | 2009-04-27 |
JP2008535813A (ja) | 2008-09-04 |
MA29372B1 (fr) | 2008-04-01 |
JP5036698B2 (ja) | 2012-09-26 |
IL185691A (en) | 2012-02-29 |
UA92908C2 (ru) | 2010-12-27 |
US20080293768A1 (en) | 2008-11-27 |
CA2602698A1 (fr) | 2006-09-28 |
US8148407B2 (en) | 2012-04-03 |
FR2883561A1 (fr) | 2006-09-29 |
KR20070114357A (ko) | 2007-12-03 |
FR2883561B1 (fr) | 2009-03-20 |
WO2006100413A9 (fr) | 2007-10-18 |
IL185691A0 (en) | 2008-01-06 |
MX2007011849A (es) | 2007-10-03 |
NO20074609L (no) | 2007-12-12 |
WO2006100413A2 (fr) | 2006-09-28 |
KR101336547B1 (ko) | 2013-12-03 |
CN101146817B (zh) | 2011-08-17 |
CN101146817A (zh) | 2008-03-19 |
TNSN07362A1 (fr) | 2008-12-31 |
AU2006226251A1 (en) | 2006-09-28 |
WO2006100413A3 (fr) | 2006-11-09 |
BRPI0609211A2 (pt) | 2010-03-02 |
RU2412195C2 (ru) | 2011-02-20 |
AU2006226251B2 (en) | 2012-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7250522B2 (en) | Method for selective preparation of aryl 5-thio-β-D-aldohexopyranosides | |
TW200837072A (en) | Novel 1, 4-benzothiepine 1, 1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof | |
BG65867B1 (bg) | Глюкопиранозилокси бензилбензенови производни, лекарствени състави, които ги съдържат и междинни съединения за получаване на тези прозводни | |
TW201014822A (en) | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof | |
JPWO2004106352A1 (ja) | アルドヘキソピラノース中間体の製造法 | |
EP0365397A2 (fr) | Nouveaux beta-D-phényl-thioxylosides, leur procédé de préparation et leur utilisation en thérapeutique | |
EP1861411A2 (fr) | Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique | |
EP1668021B1 (fr) | Nouveaux composes du thioxylose, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique | |
EP2041153B1 (fr) | Nouveaux derives de 5-thioxylopyranose | |
FR2906247A1 (fr) | Nouveaux derives de 5-thioxylopyranose | |
EP2066683A1 (fr) | Derives de 5 - thioxylopyranose et leur utilisation en therapeutique | |
FR2510574A1 (fr) | Kanamycines modifiees en 2', leur procede d'obtention et leur utilisation comme agents antibacteriens | |
JPH05163292A (ja) | 3’及び/又は4’位の水酸基を化学修飾したエルサマイシンa誘導体の製造法 | |
BE549741A (fr) | ||
JPH0764826B2 (ja) | ベンズイミダゾール誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070912 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
R17D | Deferred search report published (corrected) |
Effective date: 20071018 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: LABORATOIRES FOURNIER S.A. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1111167 Country of ref document: HK |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: LABORATOIRES FOURNIER SA |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: INVENTIVA |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: INVENTIVA |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
17Q | First examination report despatched |
Effective date: 20130502 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20130715 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20140109 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140520 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1111167 Country of ref document: HK |